CME vs TRU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

CME

46.7
AI Score
VS
CME Wins

TRU

40.0
AI Score

Investment Advisor Scores

CME

47score
Recommendation
HOLD

TRU

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME TRU Winner
Forward P/E 23.8095 15.2439 TRU
PEG Ratio 4.2508 1.1721 TRU
Revenue Growth 13.0% 12.2% CME
Earnings Growth 16.1% 65.3% TRU
Tradestie Score 46.7/100 40.0/100 CME
Profit Margin 63.5% 15.8% CME
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CME 1M: +13.6% · 3M: +18.2% TRU 1M: +21.4% · 3M: +1.0%

Current Technical Phase

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71

RSI (14): 70.6 · Price: $315.87

TRU

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.5 · Price: $81.96

Fundamentals Snapshot

Metric CME TRU
Market Cap — —
Forward P/E 23.9 15.4
Trailing P/E 25.0 20.0
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 1.0% 0.6%
Operating Margin 0.7% 0.2%
EPS 12.38 4.11
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.